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ARTICLE
ZNF506-dependent positive feedback loop
regulates H2AX signaling after DNA damage
Somaira Nowsheen 1,2, Khaled Aziz1, Kuntian Luo3, Min Deng3, Bo Qin3, Jian Yuan2,4, Karthik B. Jeganathan5,
Jia Yu2, Henan Zhang6, Wei Ding6, Jan M. van Deursen5 & Zhenkun Lou 2,3
Cells respond to cytotoxic DNA double-strand breaks by recruiting repair proteins to the
damaged site. Phosphorylation of the histone variant H2AX at S139 and Y142 modulate its
interaction with downstream DNA repair proteins and their recruitment to DNA lesions. Here
we report ATM-dependent ZNF506 localization to the lesion through MDC1 following DNA
damage. ZNF506, in turn, recruits the protein phosphatase EYA, resulting in depho-
sphorylation of H2AX at Y142, which further facilitates the recruitment of MDC1 and other
downstream repair factors. Thus, ZNF506 regulates the early dynamic signaling in the DNA
damage response (DDR) pathway and controls progressive downstream signal ampliﬁcation.
Cells lacking ZNF506 or harboring mutations found in cancer patient samples are more
sensitive to radiation, offering a potential new therapeutic option for cancers with mutations
in this pathway. Taken together, these results demonstrate how the DDR pathway is
orchestrated by ZNF506 to maintain genomic integrity.
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Our genome is under constant stress, both from exogenousand endogenous agents that can lead to various forms ofDNA damage. Of the various types of DNA damage,
DNA double-strand breaks are the most lethal. Since one unre-
paired DNA double-strand break can potentially be lethal to the
cell, cells have evolved an intricate system called the
DNA damage response system to combat this threat and main-
tain genomic integrity1–3. This response to cytotoxic DNA
double-strand breaks involves accrual of DNA repair proteins to
the damaged site. This complex response system starts with the
protein kinase ATM sensing the damaged DNA and phosphor-
ylating the histone variant H2AX at its serine 139 (Ser139) resi-
due, thereby forming γ-H2AX4. γ-H2AX is required for
subsequent interaction with downstream DNA repair proteins5,6.
The mediator protein MDC1 interacts with γ-H2AX using its
BRCT domain7,8. However, before H2AX can recruit MDC1 via
its phosphorylated S139 site, it has to be dephosphorylated at
Y142 by the phosphatase EYA5,6. After MDC1 recruitment,
MDC1 in turn recruits the E3 ligase RNF8, which ubiquitylates
the polycomb group-like protein L3MBTL29. Next, another E3
ligase, RNF168, recognizes the ubiquitylated L3MBTL2 and
localizes to the sites of DNA damage9. This protein, RNF168,
ubiquitylates lysine residues on histones H2A and H2AX (K13
and K15 residues) and further ampliﬁes the response10. These
ubiquitylated histone residues are recognized by DNA
repair proteins such as 53BP1 and RAP80, which localize to the
damage site to amplify and promote DNA double-strand
break repair11–16.
As mentioned above, DNA repair is very complex with sig-
niﬁcant cross-talk between the various pathways. The DNA
double-strand break response can be simpliﬁed to two major
repair pathways: homologous recombination and non-
homologous end joining. Homologous recombination-mediated
DNA double-strand break repair is restricted to the S/G2 phase of
the cell cycle since it requires the sister chromatid as a template
for high-ﬁdelity repair. Among others, BRCA1, BRCA2, and
Rad51 are critical for efﬁcient homologous recombination-
mediated DNA double-strand break repair17–19. In contrast,
non-homologous end-joining-mediated DNA double-strand
break repair can occur throughout the cell cycle and is error
prone. Key players in this pathway include proteins such as DNA-
PK/Ku complex, 53BP1, Artemis, and Ligase IV. Regulators such
as Rev7, TIRR, UHRF1, and Rif1 dictate the choice of DNA repair
pathway20–24.
As DNA double-strand break repair pathways are often aber-
rant in cancers such as leukemia, identifying key regulators of this
pathway is important for ascertaining novel therapeutic targets.
In order to identify new regulators of this pathway, we analyzed
the sequencing data of patients with a rare type of leukemia called
T-cell prolymphocytic leukemia (T-PLL) in the Mayo Clinic
patient database. We identiﬁed ZNF506 as one of the frequently
mutated genes in this patient population. To our knowledge,
there are no reports on ZNF506 in any biological context; hence,
we proceeded to identify the function of this protein.
In this study, we reveal that ZNF506 regulates gradual H2AX
dephosphorylation at Y142. We report that DNA damage-
induced ATM-dependent phosphorylation of ZNF506 localizes it
to the DNA damage site through its interaction with MDC1.
ZNF506, in turn, facilitates recruitment of the protein phospha-
tase EYA to the DNA lesion, dephosphorylating H2AX at Y142
and leading to recruitment of MDC1 and other downstream
repair factors. In this way, ZNF506 regulates the dynamics at an
early point in the DNA damage response pathway and controls
progressive downstream signal ampliﬁcation. Overexpression of
ZNF506 confers resistance to radiation. Conversely, cells lacking
ZNF506 or harboring mutations found in patient samples are
more sensitive to radiation and DNA-damaging agents, offering a
potential new therapeutic option for cancers with mutations in
this pathway. Collectively, these results identify ZNF506 as a key
target of ATM following DNA damage and establish the function
of ZNF506 in maintaining genomic integrity through its role in
the DNA damage response pathway.
Results
ZNF506 localizes to DNA lesions in an MDC1-dependent
manner. Since the gene was identiﬁed in T-PLL, a disease char-
acterized by mutations in DNA double-strand break repair pro-
teins such as ATM25–27, we tested whether ZNF506 plays a role in
DNA double-strand break repair. We knocked down ZNF506 in
U2OS cells using short hairpin RNAs (shRNAs) and assessed
radiation-induced γ-H2AX foci, a marker for DNA double-strand
breaks4. As shown in Fig. 1a, b, downregulation of ZNF506
resulted in increase in γ-H2AX signals in the absence of exo-
genous DNA damage, suggesting endogenous DNA damage in
ZNF506-depleted cells. After ionizing radiation, ZNF506 deple-
tion did not affect the initial formation of γ-H2AX foci but
drastically attenuated the resolution of γ-H2AX foci, even 24 h
following the initial DNA damage. Using the neutral comet assay
(Supplementary Fig. 1a, b), we also found increased tail moments
in ZNF506-depleted cells, suggesting that increased DNA damage
is at least partly the cause for the increased and persistent γ-
H2AX signals observed with ZNF506 depletion. Thus, DNA
double-strand breaks persist in the absence of ZNF506 (Fig. 1a, b
and Supplementary Fig. 1a–c). Next, we wanted to check if
ZNF506 localizes to DNA double-strand break sites. We utilized
an I-Sce1-based reporter system that induces one DNA double-
strand break per cell28. As shown in Fig. 1c, ZNF506 localized to
the site of DNA double-strand break, which overlapped with the
γ-H2AX focus. This result was validated in U2OS cells where
endogenous ZNF506 formed radiation-induced puncta that
overlapped with γ-H2AX (Fig. 1d and Supplementary Fig. 1d).
Taken together, our results suggest that ZNF506 localizes to the
DNA double-strand break site following DNA damage and has
functional implications in DNA damage response.
Next, we wanted to identify factor(s) required to retain
ZNF506 at the damage site. We found that MDC129–31, an
important mediator of the DNA damage response pathway, is
required for ZNF506 focus formation. In MDC1 knockout cells,
ZNF506 localization to DNA double-strand break sites was
signiﬁcantly impaired (Fig. 1e, f and Supplementary Fig. 1e). Co-
immunoprecipitation experiments in HEK293 cells irradiated to
induce DNA damage revealed that ZNF506 interacts with MDC1
upon DNA damage (Fig. 1g). This puts forth the model that
MDC1 is required for the retention of phosphorylated ZNF506 at
DNA damage sites.
ZNF506 is phosphorylated by ATM upon DNA damage. We
next investigated how MDC1 helps retain ZNF506 at DNA
damage sites. MDC1 contains tandem BRCT domains and a
forkhead-associated (FHA) domain that recognizes phosphory-
lated serine/threonine-containing motifs32–34. We found that the
MDC1-ZNF506 interaction was dependent on the FHA, but not
BRCT domain of MDC1 both by co-immunoprecipitation and
glutathione-S-transferase (GST) pull-down assays (Fig. 2a, b).
Because the FHA domain recognizes phosphorylated motifs, we
next hypothesized that ZNF506 might be phosphorylated. To
assess if indeed ZNF506 is phosphorylated upon DNA damage,
we expressed FLAG-tagged ZNF506 in HEK293 cells, exposed the
cells to radiation, and performed co-immunoprecipitation
experiments. As shown in Fig. 2c, probing the blots with pSQ/
TQ antibody that recognizes putative ATM phosphorylation sites
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detected signiﬁcant ZNF506 phosphorylation. Treatment with the
ATM inhibitor Ku55933 attenuated this phosphorylation, sug-
gesting that indeed ATM was the protein kinase responsible for
this process. To identify the possible ATM phosphorylation sites
on ZNF506, we analyzed the protein sequence for ATM phos-
phorylation sites which are typically pSQ/TQ35. As shown in
Supplementary Fig. 2a, a possible threonine (T140) site was
identiﬁed in ZNF506. Mutation of the site to alanine (T140A)
abrogated DNA damage-induced ZNF506 phosphorylation
(Fig. 2c). Taken together, this suggests that ZNF506 is phos-
phorylated by ATM at the T140 residue upon DNA damage.
Phosphorylation of ZNF506 was found to be critical for its
interaction with MDC1 since no DNA damage-induced interac-
tion between ZNF506 and MDC1 was detected in cells expressing
the ZNF506 phosphorylation mutant T140A (Fig. 2d). Using
puriﬁed GST-tagged FHA protein and either non-phosphorylated
or phosphorylated ZNF506 peptides, we validated that this
binding between ZNF506 and MDC1 is, in fact, a direct
interaction (Fig. 2e). Collectively, these results establish that the
FHA domain of MDC1 and phosphorylated T140 residue of
ZNF506 mediate their interaction. Based on our results, one can
predict that ZNF506 phosphorylation is required for its focus
formation. Indeed, as shown in Fig. 2f, g, the phosphorylation
mutant was unable to localize to sites of DNA damage as
apparent from lack of radiation-induced foci, suggesting that
ATM-mediated phosphorylation of ZNF506 is required for
its interaction with MDC1 and its localization to the sites
of DNA damage.
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Fig. 1 ZNF506 localizes to DNA double-strand break in an MDC1-dependent manner. a, b Downregulation of ZNF506 using shRNAs leads to persistent
DNA double-strand breaks. a Representative images of γ-H2AX foci (green) in U2OS cells after the indicated treatments and indicated time following 2 Gy
irradiation (IR). Nucleus is stained with DAPI (blue). b Quantiﬁcation of γ-H2AX foci in U2OS cells after the indicated treatment and time following IR.
c ZNF506 localizes to the DNA double-strand break site in U2OS I-SceI cells where one DNA double-strand break is induced per cell using triamcinolone
acetonide (red). This ZNF506 focus (green) overlaps with γH2AX (blue). The yellow box locates the site of the cut. The white circle outlines the nucleus.
d ZNF506 forms radiation-induced puncta that overlaps with γ-H2AX in U2OS cells. Cells were stained for γ-H2AX foci (green). Nucleus is stained with
DAPI (blue). Endogenous ZNF506 shows diffuse nuclear staining without DNA damage but forms discrete nuclear foci that overlaps with γ-H2AX upon
treatment with 2 Gy IR (red). e, f MDC1 is required for recruitment of ZNF506 to double-strand break sites. U2OS cells in which MDC1 was knocked out
using CRISPR were exposed to 2 Gy IR and stained for the indicated foci. Nucleus is stained with DAPI (blue). e Quantiﬁcation of ZNF506 foci in U2OS cells
wild-type or knockout for MDC1 and treated as indicated. f Representative images of the indicated foci in U2OS cells an hour after 2 Gy IR. g Endogenous
ZNF506 interacts with MDC1 upon DNA damage. Shown are the representative data (mean ± SEM) from three independent experiments in b and e. **p <
0.01 by ANOVA comparing the knockdown groups to control at each time point in b, and control to knockout with each treatment condition in
e. Representative images of three independent experiments are shown in a, c, d, and f. Scale bars, 10 µm. Representative western blots in g are provided
from three biologically independent experiments. Unprocessed blots are provided in Supplementary Fig. 5
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05161-0 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2736 | DOI: 10.1038/s41467-018-05161-0 |www.nature.com/naturecommunications 3
ZNF506 recruits EYA for H2AX dephosphorylation at Y142.
The DNA double-strand break repair is a complex dynamic
process with signiﬁcant cross-talk between various players in the
pathway. In order to assess the step(s) regulated by ZNF506, we
systematically checked irradiation (IR)-induced foci formation of
multiple DNA double-strand break repair proteins. The signaling
cascade starts with phosphorylation of key substrates such as
H2AX and MDC1 around the DNA double-strand break site by
the protein kinase ATM. Phosphorylation of H2AX at S139 (γ-
H2AX) recruits the mediator protein MDC1 to the double-strand
break site. MDC1 in turn acts as an adaptor for signal ampliﬁ-
cation by recruiting proteins such as NBS1, RNF8, and so on.
These proteins further amplify the signal and recruit down-
stream DNA repair proteins such as 53BP1 and BRCA1 to
mediate efﬁcient DNA double-strand break repair36. We sys-
tematically explored the focus formation of key DNA double-
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Fig. 2 DNA damage-induced ATM-dependent phosphorylation of ZNF506 is required for its MDC1-mediated recruitment to the DNA double-strand break
site. a ZNF506 interacts with the FHA domain of MDC1 upon DNA damage. Deletion of the FHA domain (ΔFHA) abrogates the interaction between MDC1
and ZNF506 in HEK293 cells. MDC1 knockout cells were transfected with the indicated plasmids and exposed to radiation. An hour later, interaction
between endogenous ZNF506 and MDC1 fragments were assessed. b ZNF506 interacts with the FHA domain of MDC1 in vitro. c ATM phosphorylates
ZNF506 at the T140 residue in HEK293 cells following DNA damage. ATM inhibitor (ATMi) KU55933 was used as a control. Cells were transfected with
the indicated tagged constructs, co-immunoprecipitation was performed, and the blot was probed with pSQ/TQ antibody. d Phosphorylation of ZNF506 is
required for its interaction with MDC1. Endogenous ZNF506 was knocked out in HEK293 cells using CRISPR and the indicated FLAG-tagged constructs
were expressed. Cells were exposed to the indicated doses of radiation. Lysates were collected after an hour and immunoprecipitation with FLAG was
performed. Blots were probed with the indicated antibodies. e The FHA domain of MDC1 directly interacts with phosphorylated ZNF506. The indicated
peptides of ZNF506 (T140 (control) and pT140) were incubated with GST control vector or GST-tagged FHA domain of MDC1. The blot was probed with
the indicated antibody. f, g Phosphorylation of ZNF506 is required for its recruitment to DNA double-strand break sites in U2OS cells. Mutation of the
phosphorylation site on ZNF506 abrogates its localization to DSB sites. Cells were exposed to 2 Gy irradiation (IR) and stained for the indicated foci (red).
Nucleus is stained with DAPI (blue). f Quantiﬁcation of the indicated foci in U2OS cells after the indicated treatment. g Representative images of the
indicated foci in U2OS cells an hour after 2 Gy IR. Shown are the representative data (mean ± SEM) from three independent experiments in f.
Representative images of three independent experiments are shown in g. Scale bars, 10 µm. Representative western blots in a–e are provided from three
biologically independent experiments. Unprocessed blots are provided in Supplementary Fig. 5
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strand break repair proteins in ZNF506-depleted cells. Interest-
ingly, our results revealed that ZNF506 regulates MDC1 accu-
mulation at DNA double-strand break sites. As shown in Fig. 3a
and Supplementary Fig. 3a, b, knockdown of ZNF506 attenuated
the formation of radiation-induced MDC1 foci. Therefore,
ZNF506 and MDC1 accumulation are dependent on each other,
likely forming a positive feedback loop. As expected, the focus
formation of DNA damage response factors downstream of
MDC1, such as RNF8, BRCA1, and 53BP1, were also compro-
mised in ZNF506-depleted cells. Since ZNF506 is a zinc-ﬁnger
protein, we assessed if the effects observed were independent of
transcription. Indeed, knockdown of ZNF506 using shRNAs did
not affect the protein level of these repair factors (Supplementary
Fig. 3a). This effect on the recruitment of DNA repair factors to
sites of DNA damage was validated in ZNF506-knockout U2OS
cells as well (Supplementary Fig. 3c–e). As further conﬁrmation
of the importance of wild-type ZNF506 in mediating this effect,
radiation-induced foci formation of MDC1 and RNF8 was
restored with the expression of wild-type but not the T140
phosphorylation mutant (T140A) of ZNF506 in ZNF506-
knockout U2OS cells (Supplementary Fig. 3f–h). Taken toge-
ther, our data suggest that ZNF506 is a key player in the DNA
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double-strand break repair pathway through its interaction
with MDC1.
It is apparent from our results so far that ZNF506 modulates
the DNA double-strand break repair pathway somewhere
between H2AX and MDC1. MDC1 is recruited by H2AX to the
sites of DNA damage through a direct interaction between its
BRCT domains and pS139 of H2AX7. We found that ZNF506 did
not affect H2AX S139 phosphorylation (γH2AX, Fig. 1). There-
fore, ZNF506 might regulate MDC1 focus formation through
other mechanisms. It has been reported that H2AX is
phosphorylated at the basal level (without DNA damage
induction) at tyrosine 142 (Y142) by Williams–Beuren syndrome
transcription factor (WSTF)5. Upon DNA damage, ATM
phosphorylates the Ser139 residue while EYA (EYA1/ EYA3), a
phosphatase, removes the phosphate group at Y1426. This allows
for the interaction between MDC1 and H2AX, promoting signal
ampliﬁcation. To test whether ZNF506 plays a role in this
interplay, we examined the effect of ZNF506 knockdown
on H2AX pY142. Consistent with the earlier report, DNA
damage induced Y142 dephosphorylation of H2AX (Fig. 3b).
Loss of either ZNF506 or EYA1 blocked H2AX dephosphoryla-
tion, suggesting that ZNF506 regulates H2AX Y142 phosphoryla-
tion (Fig. 3b).
We next explored how ZNF506 regulates H2AX Y142
phosphorylation. Interestingly, we found a DNA damage-
induced interaction between ZNF506 and EYA1. As shown in
Fig. 3c, a robust interaction between the proteins was observed
upon DNA damage. It had also been reported that EYA1 localizes
to DNA double-strand break sites upon DNA damage6, although
the underlying mechanism is still not clear. It is possible that
ZNF506 might promote EYA1 recruitment. Indeed, we observed
that EYA1 was unable to redistribute to DNA damage loci when
ZNF506 was knocked down using shRNAs in U2OS cells (Fig. 3d, e
and Supplementary Fig. 3i). It has been previously reported that
phosphorylation of EYA3 at S219 residue is critical for its
localization to the DNA damage site6. Indeed, mutation of the
S219 residue of EYA3 to S219A abolished its interaction with
ZNF506 (Fig. 3f). Therefore, ZNF506 is critical for the
recruitment of EYA1/3 to DNA double-strand break sites and
subsequent dephosphorylation of H2AX at Y142 residue to
facilitate MDC1 recruitment, forming a positive feedback loop to
facilitate mobilization of downstream repair factors and ampli-
ﬁcation of the repair signals.
We also investigated how ZNF506 binds EYA1/3. ZNF506 has
one Krüppel-associated box (KRAB) and eight zinc-ﬁnger
domains (Supplementary Fig. 3j). To identify the domain(s)
critical for its role in DNA damage response, the indicated
deletion mutants were generated. As shown in Fig. 3g, deletion of
the zinc-ﬁnger domains (ΔZN) abrogated the DNA damage-
induced interaction between ZNF506 and EYA1. In accordance
with these data, a defect in DNA damage-mediated H2AX
dephosphorylation was observed with the zinc-ﬁnger deletion
mutant (ΔZN, Fig. 3h). Based on our data that MDC1 binds
ZNF506 and ZNF506 binds EYA1, one can predict that MDC1
could interact with EYA1 through ZNF506. Indeed, in ZNF506-
knockout cells, there was no MDC1-EYA1 interaction (Fig. 3i). In
cells reconstituted with WT ZNF506, there was a robust DNA
damage-induced MDC1-EYA1 interaction. However, in cells
reconstituted with ZNF506 T140A, which disrupts the MDC1-
ZNF506 interaction, the MDC1-EYA1 interaction was abolished
(Fig. 3i), suggesting that ZNF506 mediates the MDC1-EYA
interaction. These results establish ZNF506 as a mediator protein
to facilitate EYA recruitment to DNA damage sites and H2AX
Y142 dephosphorylation.
ZNF506 is required for the maintenance of genomic stability. If
our hypothesis that ZNF506 regulates H2AX modiﬁcation upon
DNA damage is correct, we expect cells with aberrant or non-
functional ZNF506 to demonstrate signiﬁcant genomic instability.
To assess if that in fact is true, we knocked out ZNF506 in normal
human ﬁbroblasts and assessed the number of cells displaying
micronuclei formation, a marker of genomic instability37. We
observed a drastic increase in micronuclei formation with
ZNF506 loss, suggesting that the protein is important for the
maintenance of genomic integrity (Fig. 4a and Supplementary
Fig. 4a). Since ZNF506 is aberrant in leukemia, we wanted to
assess the role of ZNF506 in class switch recombination. As
shown in Fig. 4b and Supplementary Fig. 4b, downregulation of
ZNF506 with shRNAs drastically reduced recombination. This
result further substantiates the claim that ZNF506 plays a phy-
siologic role and is important for DNA double-strand break
repair. Furthermore, cells with ZNF506 knocked out or expres-
sing the phosphorylation deﬁcient ZNF506 T140A mutant were
also hypersensitive to radiation, supporting that ZNF506 is
important for proper DNA repair (Fig. 4c and Supplementary
Fig. 4c).
Analysis of the TCGA database revealed that mutations in
ZNF506 are frequently observed in various malignancies. In fact,
aberration in ZNF506-EYA-H2AX axis is observed in up to 50%
of some malignancies (TCGA Research Network:
http://cancergenome.nih.gov/), suggesting that this pathway plays
a critical role in the maintenance of genomic integrity. Of the
various mutations, R258 and R260 localized in the zinc-ﬁnger
domain were mutated in both our T-PLL patient samples as well
as lung adenocarcinoma samples (TCGA Research Network:
Fig. 3 ZNF506 recruits EYA for H2AX dephosphorylation at Y142 upon DNA damage. a Knockdown of ZNF506 affects localization of DNA repair proteins
to the DNA double-strand break site. b ZNF506 regulates H2AX dephosphorylation upon DNA damage. c DNA damage induces interaction between
ZNF506 and EYA1. d, e, ZNF506 is required for the recruitment of EYA1 to DNA double-strand break sites. Cells were exposed to 2 Gy irradiation (IR) and
stained for EYA1 focus formation (red). Nucleus is stained with DAPI (blue). d Quantiﬁcation of EYA1 foci in U2OS cells after the indicated treatment.
e Representative images of EYA1 foci in U2OS cells. f Phosphorylation of EYA3 is required for its interaction with ZNF506. Either wild-type (WT) or the
phosphorylation mutant of EYA3 (S219A) were expressed in HEK293 cells. Cells were exposed to 10 Gy IR and co-immunoprecipitation was performed.
g The zinc-ﬁnger domain of ZNF506 is critical for its interaction with EYA1. The indicated FLAG-tagged constructs of ZNF506 (WT: wild-type; ΔKRAB:
deletion of KRAB domain; and ΔZN: deletion of zinc-ﬁnger domains) were expressed in HEK293 cells in which the endogenous ZNF506 had been knocked
out using CRISPR. Cells were exposed to 10 Gy IR. Lysates were collected after an hour, co-immunoprecipitation was performed, and blots were probed
with the indicated antibodies. h The zinc-ﬁnger domain of ZNF506 is critical for its role in H2AX dephosphorylation at Y142. The indicated HA-tagged
constructs of ZNF506 (WT: wild-type and ΔZN: deletion of zinc-ﬁnger domains) and FLAG-tagged H2AX were expressed in HEK293 cells in which the
endogenous ZNF506 had been knocked out using CRISPR. Co-immunoprecipitation was performed. i Phosphorylation of ZNF506 is required for the
interaction between EYA1 and MDC1. Shown are the representative data (mean ± SEM) from three independent experiments in a, d. **p < 0.01 using
ANOVA for vector vs. shRNA for each treatment condition (no IR or IR) in a, d. Representative images of three independent experiments are shown in
e. Scale bars, 10 µm. Representative western blots in b, c and f- i are provided from three biologically independent experiments. Unprocessed blots are
provided in Supplementary Fig. 5
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http://cancergenome.nih.gov/, Fig. 4d). To assess the physiologic
relevance of these mutations, we constructed patient mimetic
mutants and assessed the effect of these mutations on DNA
damage response by assaying for γ-H2AX, MDC1, 53BP1, and
BRCA1 foci formation. As shown in Fig. 4e and Supplementary
Fig. 4d–g, the initial formation of γ-H2AX was unaffected by
these mutations. However, foci formation of MDC1 and down-
stream repair proteins were drastically reduced. In U2OS cells
knocked out for ZNF506 and subsequently reconstituted with
either wild-type or the phosphorylation mutant (T140A), as
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expected, wild-type ZNF506 was able to rescue the foci formation
of these critical DNA repair proteins, while the ZNF506 T140A
was unable to do so (Supplementary Fig. 4d–f). To explore the
mechanism of this observed defect, co-immunoprecipitation
experiment with the various ZNF506 patient mimetic mutants
was performed in irradiated HEK293 cells in which endogenous
ZNF506 had been knocked out. Interestingly, the mutations in
ZNF506 disrupted its interaction with EYA. However, the
interaction with MDC1 was unaffected (Fig. 4f). Collectively,
this suggests that the patient mimetic mutations block efﬁcient
DNA double-strand break repair, which can subsequently lead to
genomic instability. Finally, due to the defects in DNA double-
strand break repair observed with either loss or mutations in
ZNF506, we expect cells harboring these mutations to be sensitive
to DNA-damaging agents such as radiation. Indeed, cells
mimicking the mutations found in patients were sensitive to
radiation (Fig. 4g). Consistently, the ZNF506 gene is frequently
dysregulated in various cancers including lung and breast cancers,
where low ZNF506 mRNA levels in breast and lung cancers
correlated with lower survival probability and worse prognosis
(Supplementary Fig. 4h–i)38,39. This is consistent with the notion
that genomic instability is often associated with poor prognosis.
Discussion
DNA double-strand break repair and chromatin/histone mod-
iﬁcations are intricately linked. Histone modifying enzymes play
an important role in DNA damage response since histone tails
and core domains demonstrate DNA damage-induced mod-
iﬁcations such as phosphorylation and ubiquitylation. Regulation
of these processes is important for proper DNA damage response
and signal ampliﬁcation. In this current study, we highlight a new
regulatory mechanism controlling histone H2AX function. It is
believed that the Y142 residue of H2AX is phosphorylated under
basal conditions by WSTF5. In response to DNA damage, H2AX
is phosphorylated at S139 by the protein kinases ATM/ATR4.
This modiﬁcation is associated with concurrent progressive
dephosphorylation of Y142 by the protein phosphatase EYA6,40.
However, it is still unclear what factor(s) determine the temporal
switch from the diphosphorylated to the monophosphorylated
state. Here we identiﬁed a new protein ZNF506 that regulates the
modiﬁcation of one of the earliest events occurring at DNA
double-strand breaks, the gradual dephosphorylation of H2AX at
Y142 by the phosphatase, EYA. This step is required for the
recruitment of downstream repair proteins and ampliﬁcation of
the repair signal. Our results imply a positive feedback loop
between MDC1 and ZNF506, which helps amplify the DNA
damage response signal. In addition, ZNF506 deﬁciency leads to
obvious genomic instability. For instance, similar to H2AX deﬁ-
ciency, lack of ZNF506 leads to defective class switch
recombination. Search of cancer databases such as the TCGA
supports a vital role of ZNF506 in tumor suppression and
maintenance of genomic stability.
Zinc-ﬁnger proteins have been previously associated with DNA
damage response. For instance, KRAB-associated protein 1
(KAP1) is a transcriptional co-repressor that regulates non-
homologous end-joining-mediated DNA double-strand break
repair41,42. In response to double-strand breaks, KAP1 is phos-
phorylated by ATM. This induces changes in chromatin con-
formation leading to chromatin decondensation and allows for
the accrual of proteins in DNA damage response. Similarly,
promyelocytic leukemia (PML)-Associated Repressor Of Tran-
scription (PAROT) possesses both KRAB and zinc-ﬁnger
domains and associates with heterochromatin protein 1 (HP1)
family of proteins to induce transcriptional repression43. Like
many proteins involved in DNA damage response, PAROT is
present within the PML nuclear bodies (PML-NBs). Since PML-
NBs have been shown to be tumor suppressors and regulate DNA
repair, PAROT may have a similar function, though this has not
been validated yet. Another example of proteins possessing zinc-
ﬁnger domains is the poly (ADP-ribose) polymerase (PARP)
family of proteins. The role of PARP1 in DNA damage response
has been well studied and the protein has been extensively
exploited for cancer therapy44–47. Protein poly ADP-ribosylation
(PARylation), a widespread post-translational modiﬁcation at
DNA lesions catalyzed by PARP proteins, regulates a number of
biological processes including chromatin reorganization, DNA
damage response, transcriptional regulation, apoptosis, and
mitosis. PARP1 recognizes DNA damage through its N-terminal
DNA-binding domain, which consists of a tandem repeat of zinc-
ﬁnger domain. Zinc-ﬁnger domains from separate PARP1
molecules form a strand break recognition module that activates
PARP1 by facilitating its dimerization and subsequent trans-
automodiﬁcation48. Another example is the ubiquitin ligase
CHFR which possesses a conserved putative C2H2 zinc-ﬁnger
motif at its carboxy terminus and is important for the initial
ubiquitylation at DNA damage sites49,50. As can be seen from
these examples, even though zinc-ﬁnger proteins have similar
structures, they are involved in a variety of roles. As such,
ZNF506 may have roles other than the one outlined in this study
and further studies are warranted to identify these functions.
EYA is a class of highly conserved proteins. Four family
members have been identiﬁed so far: EYA1, EYA2, EYA3, and
EYA4. The EYA family of tyrosine phosphatases has been shown
to be required for cell survival and differentiation51. Loss-of-
function mutations in EYA1 leads to branchio-oto-renal syn-
drome, further suggesting that the gene is important for normal
cellular function52. EYA is the ﬁrst transcriptional activator
identiﬁed that harbor intrinsic phosphatase activity53. One of the
Fig. 4 ZNF506 is required for the maintenance of genomic stability. a Loss of ZNF506 leads to genomic aberrations as indicated by micronuclei formation.
ZNF506 was knocked out in normal human ﬁbroblasts using CRISPR. Cells were stained with DAPI to assess micronuclei formation. Inset, representative
image of cell with micronucleus. b ZNF506 is required for class switch recombination. Shown is a representative image of IgM to IgA conversion with
treatment (left panel). c Loss of ZNF506 or lack of ZNF506 phosphorylation sensitizes cells to radiation. d Mutations in T-PLL identiﬁed in our patient
sample. e The mutations in ZNF506 that were identiﬁed in patient samples lead to aberrant DNA damage response. f The patient mimetic mutations of
ZNF506 disrupts the interaction between EYA1 and ZNF506 but not MDC1 and ZNF506. g The patient mimetic mutations of ZNF506 sensitizes cells to
irradiation (IR). h Model for the role of ZNF506 in response to DNA double-strand break. We propose that ATM-mediated phosphorylation of ZNF506
promotes its interaction with MDC1 and recruits it to the DNA double-strand break site. It subsequently recruits the phosphatase EYA to the damage site.
EYA, in turn, dephosphorylates H2AX at Y142 to recruit downstream repair factors and gradually amplify the DNA damage response for proper DNA
double-strand break signaling. Shown are the representative data (mean ± SEM) from three independent experiments in a–c, e, and g. **p < 0.01 by
ANOVA for control vs. each shRNA in b. **p < 0.01 by ANOVA for vector and ZNF506 sgRNA+ FLAG ZNF506 WT vs. all other groups at each dose of IR
in c. **p < 0.01 by ANOVA for ZNF506 sgRNA+ FLAG ZNF506 WT vs. all other groups with IR in e. **p < 0.01 by ANOVA for vector and ZNF506 sgRNA
+ FLAG ZNF506 WT vs. all other groups at each dose of IR in g. Representative western blots in f are provided from three biologically independent
experiments. Unprocessed blots are provided in Supplementary Fig. 5
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lingering questions in the ﬁeld is what dictates the distinct roles of
this family of phosphatases. Recent breakthrough in under-
standing EYA function is the ﬁnding that EYA1 and EYA3 play
vital roles in DNA repair vs. cell death decision after DNA
damage6,40. Interestingly, the two phosphatases cannot compen-
sate for the loss of the other6,40. So far, three substrates have been
identiﬁed for EYA: H2AX, the atypical protein kinase C zeta, and
the estrogen receptor-beta6,54–57. Increased EYA activity has been
associated with tumor cell migration, invasion, and transforma-
tion58. However, detailed studies of the role of EYA in onco-
genesis are lacking. Given that EYA has complex roles with its
functions in transcriptional regulation and tyrosine depho-
sphorylation, it is likely a combination of activities that leads to
cancer development.
Prior to our study, it was known that H2AX is phosphorylated
at its Y142 residue by WSTF and the phosphatase EYA is
required for its dephosphorylation. This dephosphorylation is
important for the proper function of H2AX in recruiting MDC1
to facilitate DNA repair. Failure to remove the phosphate group
compromises MDC1 recruitment and DNA repair, pushing the
cells towards apoptosis as the dephosphorylated H2AX recruits
the c-Jun N-terminal protein kinase 1 (JNK1) kinase6. ATM-
mediated phosphorylation of EYA3 at S219 is required for its
recruitment to the sites of DNA damage6. It was unclear what
dictates this early event in the DNA damage response and how
EYA localizes to the DNA lesion. Our study reveals how a zinc-
ﬁnger protein, ZNF506 binds phosphorylated EYA and helps
EYA recruitment. ZNF506 itself is also modiﬁed by ATM and is
recruited to DNA damage sites through its interaction with
MDC1. EYA in turn dephosphorylates H2AX Y142, further
enhancing the recruitment of MDC1, ZNF506, and EYA.
Therefore, the H2AX–MDC1–ZNF506-EYA axis forms a positive
feedback loop to amplify γH2AX signaling.
We identiﬁed ZNF506 as a gene that is mutated in T-PLL. We
do not have follow-up and survival data of patients with this
extremely rare disease. However, a search of publicly available
databases suggests that high expression of ZNF506 portends
superior survival in lung and breast cancers (Supplementary
Fig. 4h, i). As such, ZNF506 expression levels may have prog-
nostic signiﬁcance in malignancies including breast and lung
cancers. In our study, we identiﬁed cancer-derived ZNF506
mutations to be defective in recruitment of DNA repair proteins
and confer sensitivity to DNA-damaging agents. This puts forth
the idea that DNA-damaging agents such as radiation may be a
therapeutic option in patients with mutations in ZNF506.
In conclusion, our ﬁndings suggest an integrated model for
how histone H2AX is regulated upon DNA damage to maintain
genomic integrity. We report a new function of ZNF506 in the
DNA damage response. We suggest that ZNF506 is a key com-
ponent in the γH2AX signaling, and it helps recruit EYA and
forms a H2AX–MDC1–ZNF506-EYA feedback loop in amplify-
ing the DNA damage response repair signal (Fig. 4h). Mutations
in ZNF506 are pathological and seen in cancer. We suggest that
patients with mutations in ZNF506 that abolish its function may
beneﬁt from treatment with DNA-damaging agents such as
radiation. Our results thus identify a key DNA damage-induced
regulation of histone H2AX, which improves our understanding
of this DNA repair pathway and allows for the design of better
therapies for patients harboring mutations in this pathway.
Methods
Cell culture. The following cell lines were purchased from ATCC: HEK293,
HEK293T, U2OS, and MDA-MB-231. The CH12F3-2a cell line was purchased
from Thermo Fisher Scientiﬁc. The human ﬁbroblast cell line utilized in this study
has been described previously59. Cell lines were maintained in Dulbecco's modiﬁed
Eagle's medium, McCoy’s 5A, or RPMI1640 with 10% fetal bovine serum (FBS) as
recommended by the manufacturer. All cell lines were veriﬁed using short tandem
repeat proﬁling by the Medical Genome facility at Mayo Clinic Center (Rochester,
MN, USA). U2OS I-SceI cells were maintained in McCoy’s 5A supplemented with
10% FBS (kindly provided by Dr. Maria Jasin, Memorial Sloan Kettering Cancer
Center, NY, USA).
Chemicals. Triamcinolone acetonide and the ATM inhibitor KU55933 (Sigma)
were used in this study.
Plasmids. LentiCRISPR v2 (Plasmid #52961, provided by Dr. Feng Zhang) was
purchased from Addgene. ZNF506, EYA1, and EYA3 complementary DNAs were
purchased from Genscript and Dharmacon. ZNF506 was subcloned into pGEX-
4T-2 vector (Clontech), CMV-FLAG, and peGFP vectors. All ZNF506 and EYA
mutants were generated by site-directed mutagenesis (Stratagene). The MDC1
plasmids have been described previously8,29,31,60.
Antibodies. Anti-BRCA1 (catalog #sc-6954, 1:200 dilution) and anti-EYA (catalog
#sc-33605, 1:500 dilution) antibodies were purchased from Santa Cruz Bio-
technology. Anti-γH2AX (catalog #05-636, 1:500 dilution), anti-53BP1 (catalog
#05-725, 1:1000 dilution), anti-MDC1 (catalog #05-1572, 1:1000 dilution), and
anti-RNF8 (catalog #09-813, 1:250 dilution) antibodies were purchased from
Millipore. Anti-SQ/TQ (catalog #2851, 1:1000 dilution) and anti-GST (catalog
#2625, 1:1000 dilution) antibodies were purchased from Cell Signaling. Anti-FLAG
(catalog #F1804, 1:500 dilution), anti-HA (catalog #H6908, 1:500 dilution), and
anti-β-actin (catalog #A2228, 1:10,000 dilution) antibodies were purchased from
Sigma. Anti-RNF8 (catalog #ab4183, 1:200 dilution), anti-ZNF506 (catalog
#ab179722, 1:250 dilution) and anti-EYA1 (catalog #ab85009, 1:250 dilution)
antibodies were purchased from Abcam. Anti-ZNF506 antibody was purchased
from Lifespan Biosciences (catalog #LS-C160889, 1:500 dilution). Anti-RNF8
antibody (1:500 dilution) was kindly provided by Dr. Xiaochun Yu (City of Hope,
CA, USA). The following secondary antibodies were used as applicable to prevent
the detection of immunoglobulin G (IgG) light or heavy chains: anti-mouse IgG
VeriBlot for IP secondary antibody (Abcam, catalog #ab131368, 1:1000 dilution),
IgG VeriBlot for IP secondary antibody (Abcam, catalog #ab131366, 1:200 dilu-
tion), mouse anti-rabbit IgG light-chain (Abcam, catalog #ab99697, 1:1000 dilu-
tion), peroxidase-AfﬁniPure goat anti-mouse IgG light-chain-speciﬁc (Jackson
Immunoresearch, catalog #115-035-174, 1:2000 dilution), peroxidase IgG fraction
monoclonal mouse anti-Rabbit IgG, light-chain-speciﬁc (Jackson Immunoresearch,
catalog #211-032-171, 1:2000 dilution), or mouse anti-rabbit IgG (conformation
speciﬁc, L27A9, Cell Signaling, catalog #3678, 1:2000 dilution).
shRNA knockdown, CRISPR knockout, and peptides. Lentiviruses for infection
of cells was performed as described previously9. ZNF506 and MDC1 CRISPR
plasmids were generated using the methods described previously61. The following
guides were used: ZNF506: CACATTTGTAGGGTTTCTCT and CGGTGTAAGC
AGTGTAAACA; MDC1: GGTGTAACGTGGAGCCAGTAGGG and GGCCTAC
CACATTCTTCCCGAGG. The following peptides were synthesized and used in
this manuscript: GLKQCLATTQRKIFQCDEY{Lys(Biotin)} and GLKQCLAT
{pThr}QRKIFQCDEY{Lys(Biotin)} (GenScript).
Immunoprecipitation, immunoblotting, and in vitro assay. We prepared cell
lysates and performed immunoprecipitation and immunoblotting as previously
described9. NETN buffer (20mM Tris-HCl, pH 8.0, 100mMNaCl, 1mM EDTA, and
0.5% Nonidet P-40) containing 10mM NaF, 50mM β-glycerophosphate, 1 mgml−1
pepstatin A, and 1 mgml−1 aprotinin was used for cell lysis. Lysates were cen-
trifuged at 9600 × g for 15 min to remove cellular debris. Proteins of interest were
immunoprecipitated by incubating lysates with 2 µg of antibody and protein A or
protein G Sepharose beads (Amersham Biosciences) anywhere from 2 h to over-
night at 4 °C. Immunocomplexes were washed with NETN buffer, separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and
probed as indicated. Standard protocols were followed for immunoblotting. For
assessment of interactions using GST-tagged proteins, GST fusion proteins were
bound to glutathione Sepharose for 3 h at 4 °C, beads were rinsed twice with
phosphate-buffered saline (PBS), incubated with indicated proteins for 1 h at 4 °C,
washed with NETN buffer, boiled in loading buffer, and bound proteins were
separated by SDS-PAGE. Blots were probed with the indicated antibodies.
Recombinant protein production. Recombinant protein was produced using the
method outlined previously9. The Escherichia coli strain BL21 was grown in LB
medium and used to express proteins. Isopropyl-β-D-thiogalactoside (0.25 mM)
was used for induction (2 h at 37 °C followed by 12 h at 16 °C). Appropriate lysis
buffer supplemented with Protease Inhibitor Cocktail (Roche) was used for cell
lysis. Proteins were puriﬁed by binding to appropriate beads (3 h at 4 °C). Next,
beads were rinsed twice with lysis buffer before the protein was ﬁnally eluted.
Immunoﬂuorescence. Immunostaining was performed as described previously9.
The following protocol was used to assess ionizing radiation induced foci: cells
were cultured on coverslips and exposed to 2 Gy IR. An hour later, depending on
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the foci to be stained, one of the following protocols were followed: (1) cells were
rinsed with PBS, pre-extracted with a solution of 20 mM HEPES, pH 7.4, 50 mM
NaCl, 3 mM MgCl2, 300 mM sucrose, and 0.5% Triton-X for 10 min at room
temperature followed by ﬁxation with 3% paraformaldehyde for 15 min at room
temperature; (2) ﬁxed with 3% paraformaldehyde for 15 min at room temperature
without a pre-extraction step; or (3) ﬁxed with 1:1 mixture of acetone: methanol at
−20 °C. Triton (0.5%) solution for 5 min at room temperature was used to per-
meabilize cells. Samples were blocked with 5% goat serum, incubated with primary
antibody for 30 min, washed three times to remove non-speciﬁc binding, incubated
with secondary antibody for 30 min, and stained with 4′,6-diamidino-2-pheny-
lindole (DAPI) to visualize nuclear DNA. Nikon eclipse 80i ﬂuorescence micro-
scope or laser scanning microscope (Zeiss LSM 880) was used for image
acquisition. At least >200 cells were assessed per condition in all experiments where
foci formation was analyzed.
Comet assay. Comet assay was performed according to the manufacturer’s pro-
tocol (Trevigen). Brieﬂy, cells were treated as indicated and collected at the spe-
ciﬁed time points. They were then embedded in low melting point agarose, allowed
to set in 4 °C, lysed under neutral conditions, and subjected to electrophoresis.
DNA was stained with Sybr green (Invitrogen). Images were acquired using Zeiss
microscope and mean tail moment was assessed using Image J with the Comet
Score plugin.
Colony formation assay. Colony formation was performed as described pre-
viously9. Cells (500–5000) were plated in triplicate in each well of 6-well plates.
After 16 h, cells were exposed to ionizing radiation, and left for 10–14 days at 37 °C
to allow colony formation. Colonies were stained with methylene blue and counted.
Results were normalized to plating efﬁciencies.
Class switch recombination. Class switch recombination was performed in
CH12F3-2a cells as described previously9,62. Brieﬂy, ZNF506 was knocked down
using shRNAs. After 40 h, cells were stimulated with the following ligands: 1 ngml−1
of recombinant human tumor growth factor-β1 (R&D Systems), 250 ngml−1
recombinant murine CD40 ligand (PerproTech), and 10 ngml−1 of recombinant
murine interleukin-4 (R&D Systems). After 60 h, cells were collected and stained with
the following antibodies: phycoerythrin-conjugated anti-murine IgA antibody (clone
11-44-2, eBiosciences, catalog #12-5994-82) for intracellular staining and ﬂuorescein
isothiocyanate-conjugated anti-murine IgM antibody (eBiosciences; catalog #11-5890-
82) for assessment of membrane IgM expression. The following buffers were used:
Cytoﬁx/Cytoperm and Perm/Wash buffers (BD Biosciences, catalog #554714). Cells
were then analyzed on a FACS Calibur (BD Biosciences) at the Mayo Clinic Flow
Cytometry Core to assess class switch from IgM (IgM+/IgA−) to IgA (IgM−/IgA+).
The data acquired were analyzed using the FlowJo software (TreeStar).
Survival analysis of cancer patients. Kaplan–Meier survival curves were gener-
ated using the Kaplan–Meier Plotter website for breast and lung cancers (http://
kmplot.com)38,39 and statistical signiﬁcance was determined by the log–rank test.
Statistics. Data in bar and line graphs are reported as mean ± SEM. Statistical
analyses were performed in GraphPad Prism with either analysis of variance
(ANOVA) or t test as applicable. More than 200 cells were counted per experiment
as indicated. The following depicts statistical signiﬁcance: *p < 0.05; **p < 0.01. All
results reported in this study were successfully repeated at least three times.
Data availability. Source data for western blots are provided in Supplementary
Fig. 5. All data supporting the ﬁndings of this study are available from the cor-
responding author on reasonable request.
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